Herpes simplex virus encephalitis in a patient receiving ustekinumab associated with extensive cerebral oedema and brainshift successfully treated by immunosuppression with dexamethasone

Herpes simplex virus (HSV) encephalitis affects 2–4 people per million/year. Immunocompomised patients can have atypical presentations of HSV encephalitis, including a lack of cerebrospinal fluid (CSF) pleocytosis. We present the case of a patient who was receiving ustekinumab therapy for psoriasis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Case Rep
Egile Nagusiak: Van Den Tooren, Harriet Kay, Bharambe, Viraj, Silver, Nicholas, Michael, Benedict D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2019
Gaiak:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700545/
https://ncbi.nlm.nih.gov/pubmed/31413050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229468
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak